000 01184 a2200313 4500
005 20250517230237.0
264 0 _c20190422
008 201904s 0 0 eng d
022 _a1473-5636
024 7 _a10.1097/CMR.0000000000000474
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOlaverria Salavaggione, Gonzalo N
245 0 0 _aAnalysis of MLN4924 (pevonedistat) as a potential therapeutic agent in malignant melanoma.
_h[electronic resource]
260 _bMelanoma research
_c10 2018
300 _a390-397 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aCell Line, Tumor
650 0 4 _aCyclopentanes
_xpharmacology
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aHumans
650 0 4 _aMelanoma
_xdrug therapy
650 0 4 _aPyrimidines
_xpharmacology
650 0 4 _aSkin Neoplasms
_xdrug therapy
650 0 4 _aSurvival Rate
700 1 _aDuggan, Megan C
700 1 _aCarson, William E
773 0 _tMelanoma research
_gvol. 28
_gno. 5
_gp. 390-397
856 4 0 _uhttps://doi.org/10.1097/CMR.0000000000000474
_zAvailable from publisher's website
999 _c28644318
_d28644318